SEGMENT AND GEOGRAPHIC INFORMATION

In October 2017, the Company leveraged the globally recognized Codman name by rebranding the Specialty Surgical Solutions segment as Codman Specialty Surgical.

The Company internally manages two global reportable segments and reports the results of its businesses to its chief operating decision maker. The two reportable segments and their activities are described below.

•

The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the precision tools and instruments business, which sells more than 60,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.


•	The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair products.

The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.

The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by reportable segment for the years ended December 31, 2018, 2017 and 2016 are as follows:



	Years Ended December 31,
	2018			2017			2016
	(In thousands)
Segment Net Sales
Codman Specialty Surgical	$	963,929		$	720,301		$	632,524
Orthopedics and Tissue Technologies	508,512			467,935			359,551
Total revenues	$	1,472,441		$	1,188,236		$	992,075
Segment Profit
Codman Specialty Surgical	$	363,336		$	292,971		$	256,629
Orthopedics and Tissue Technologies	149,510			129,697			103,852
Segment profit	512,846			422,668			360,481
Amortization	(21,160)			(20,370)			(13,862)
Corporate and other	(380,688		)	(357,494		)	(231,279		)
Operating income	$	110,998		$	44,804		$	115,340

The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment.

The Company attributes revenue to geographic areas based on the location of the customer. Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below:



	United States*		Europe		Asia Pacific		Rest of the World		Consolidated
	(In thousands)
Total revenue, net:
2018	$	1,045,887	$	201,354	$	144,253	$	80,947	$	1,472,441
2017	894,260		150,147		80,636		63,193		1,188,236
2016	765,608		120,588		59,985		45,894		992,075
Total long-lived assets:
2018	$	280,382	$	32,679	$	3,765	$	3,203	$	320,029
2017	247,154		30,942		4,189		3,044		285,329

* Includes long-lived assets in Puerto Rico.